Spots Global Cancer Trial Database for diffusion weighted imaging
Every month we try and update this database with for diffusion weighted imaging cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma | NCT00662506 | Adult Giant Cel... Adult Glioblast... Adult Gliosarco... | Cediranib Malea... Diffusion Tenso... Diffusion Weigh... Dynamic Contras... Fludeoxyglucose... Intensity-Modul... Laboratory Biom... Perfusion Magne... Positron Emissi... Temozolomide | 18 Years - | National Cancer Institute (NCI) | |
| Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery | NCT02590497 | Glioblastoma | Diffusion Weigh... Gadolinium Laboratory Biom... Magnetic Resona... Magnetic Resona... Magnetic Resona... Perfusion Magne... | - | Ohio State University Comprehensive Cancer Center | |
| Whole Body MRI With DWI for Monitoring Patients Treated for Testicular Cancer Stage II-III | NCT03436901 | Testicular Neop... | MRI with DWI vs... | 18 Years - | Aarhus University Hospital | |
| Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma | NCT06108206 | Glioblastoma Anaplastic Astr... Astrocytoma Anaplastic Olig... | Adaptive Radiot... | 18 Years - | Columbia University | |
| Quantitative MRI Assessment of Breast Cancer Therapy Response | NCT05704062 | Breast Cancer | Diffusion Weigh... Dynamic Contras... | 18 Years - | OHSU Knight Cancer Institute | |
| Non-contrast DWI for Supplemental Screening | NCT03607552 | Breast Cancer | Non-contrast DW... Non-contrast MR... | 18 Years - 80 Years | University of Washington | |
| MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer | NCT06090630 | Benign Breast N... Breast Carcinom... Malignant Breas... | Diffusion Weigh... Magnetic Resona... | 18 Years - 80 Years | Jonsson Comprehensive Cancer Center | |
| Diffusion Weighted Imaging as a Biomarker for Detection of Chemotherapy Induced Cardiotoxicity | NCT02274480 | Chemotherapy In... | cardiac MRI wit... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Application of DWI in Diagnosis of Prostate Cancer | NCT04962269 | Prostate Cancer Benign Prostati... | MRI | - | Peking University Third Hospital | |
| MR Metabolic Biomarkers for Cervical Cancer | NCT01874548 | Uterine Cervica... | 20 Years - 80 Years | Chang Gung Memorial Hospital | ||
| Whole Body MRI With DWI for Monitoring Patients Treated for Testicular Cancer Stage II-III | NCT03436901 | Testicular Neop... | MRI with DWI vs... | 18 Years - | Aarhus University Hospital | |
| MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy | NCT00660543 | Adult Brain Gli... | Gadolinium Ferumoxytol Non... Dynamic Contras... Dynamic Suscept... Diffusion Weigh... MRI-Based Angio... | 18 Years - | OHSU Knight Cancer Institute | |
| Whole Body MRI With DWI for Monitoring Patients Treated for Testicular Cancer Stage II-III | NCT03436901 | Testicular Neop... | MRI with DWI vs... | 18 Years - | Aarhus University Hospital | |
| MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer | NCT01992861 | Cervical Adenoc... Cervical Adenos... Cervical Squamo... Cervical Undiff... Recurrent Cervi... Stage IB2 Cervi... Stage II Cervic... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage IIIA Cerv... Stage IIIB Cerv... Stage IVA Cervi... | Computed Tomogr... Diffusion Weigh... Dynamic Contras... Fludeoxyglucose... Magnetic Resona... Positron Emissi... | 18 Years - | University of Washington | |
| Application of DWI in Diagnosis of Prostate Cancer | NCT04962269 | Prostate Cancer Benign Prostati... | MRI | - | Peking University Third Hospital | |
| 18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy | NCT01991977 | Malignant Gliom... | Diffusion Weigh... Fluorine F 18 F... Intensity-Modul... Perfusion Magne... Positron Emissi... Quality-of-Life... Temozolomide | 18 Years - | Mayo Clinic | |
| Application of DWI in Diagnosis of Prostate Cancer | NCT04962269 | Prostate Cancer Benign Prostati... | MRI | - | Peking University Third Hospital | |
| PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia | NCT02390635 | Acute Myeloid L... Acute Promyeloc... | Computed Tomogr... Diffusion Weigh... Fludeoxyglucose... Gadolinium Magnetic Resona... Positron Emissi... Three-Dimension... | 18 Years - | M.D. Anderson Cancer Center | |
| Quantitative Methods for Supplementing Contrast-Enhanced Magnetic Resonance Imaging of Breast Cancer | NCT02058758 | Breast Cancer | Magnetic Resona... | 18 Years - | University of Minnesota | |
| Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery | NCT02590497 | Glioblastoma | Diffusion Weigh... Gadolinium Laboratory Biom... Magnetic Resona... Magnetic Resona... Magnetic Resona... Perfusion Magne... | - | Ohio State University Comprehensive Cancer Center | |
| 18F-DOPA-PET in Planning Surgery in Patients With Gliomas | NCT02020720 | Malignant Gliom... Recurrent Brain... | Biopsy Computed Tomogr... Diffusion Weigh... Fluorine F 18 F... Laboratory Biom... Perfusion Magne... Positron Emissi... Therapeutic Con... | 7 Years - | Mayo Clinic | |
| MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer | NCT01992861 | Cervical Adenoc... Cervical Adenos... Cervical Squamo... Cervical Undiff... Recurrent Cervi... Stage IB2 Cervi... Stage II Cervic... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage IIIA Cerv... Stage IIIB Cerv... Stage IVA Cervi... | Computed Tomogr... Diffusion Weigh... Dynamic Contras... Fludeoxyglucose... Magnetic Resona... Positron Emissi... | 18 Years - | University of Washington | |
| PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia | NCT02390635 | Acute Myeloid L... Acute Promyeloc... | Computed Tomogr... Diffusion Weigh... Fludeoxyglucose... Gadolinium Magnetic Resona... Positron Emissi... Three-Dimension... | 18 Years - | M.D. Anderson Cancer Center | |
| PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia | NCT02390635 | Acute Myeloid L... Acute Promyeloc... | Computed Tomogr... Diffusion Weigh... Fludeoxyglucose... Gadolinium Magnetic Resona... Positron Emissi... Three-Dimension... | 18 Years - | M.D. Anderson Cancer Center | |
| An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response | NCT04796818 | Metastatic Colo... Metastatic Mali... Resectable Colo... Stage IV Colore... Stage IVA Color... Stage IVB Color... Stage IVC Color... | Diffusion Weigh... | 18 Years - | M.D. Anderson Cancer Center | |
| Application of DWI in Diagnosis of Prostate Cancer | NCT04962269 | Prostate Cancer Benign Prostati... | MRI | - | Peking University Third Hospital | |
| Factors Influencing Volumetric MR-HIFU Ablation of Uterine Fibroids | NCT02386137 | Uterine Fibroid | Contrast-enhanc... | 18 Years - | University Hospital, Bordeaux | |
| Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma | NCT02359565 | Constitutional ... Lynch Syndrome Malignant Gliom... Recurrent Brain... Recurrent Child... Recurrent Diffu... Recurrent Medul... Refractory Brai... Refractory Diff... Refractory Epen... Refractory Medu... | Biospecimen Col... Conventional Ma... Diffusion Tenso... Diffusion Weigh... Dynamic Contras... Dynamic Suscept... Magnetic Resona... Pembrolizumab | 1 Year - 30 Years | National Cancer Institute (NCI) | |
| Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems | NCT03961776 | Rectal Adenocar... | MRI-guided radi... | 18 Years - | Institut Paoli-Calmettes | |
| MR Elastography Parameters Impact on MR-HIFU Efficacy in Uterine Fibroids | NCT04345003 | Uterine Fibroid | Myoma elastogra... | 18 Years - | University Hospital, Bordeaux | |
| Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma | NCT06108206 | Glioblastoma Anaplastic Astr... Astrocytoma Anaplastic Olig... | Adaptive Radiot... | 18 Years - | Columbia University | |
| Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma | NCT00662506 | Adult Giant Cel... Adult Glioblast... Adult Gliosarco... | Cediranib Malea... Diffusion Tenso... Diffusion Weigh... Dynamic Contras... Fludeoxyglucose... Intensity-Modul... Laboratory Biom... Perfusion Magne... Positron Emissi... Temozolomide | 18 Years - | National Cancer Institute (NCI) | |
| MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy | NCT00660543 | Adult Brain Gli... | Gadolinium Ferumoxytol Non... Dynamic Contras... Dynamic Suscept... Diffusion Weigh... MRI-Based Angio... | 18 Years - | OHSU Knight Cancer Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
